Thermo Fisher Scientific Increase Decrease In Operating Capital Excluding Deferred Taxes decreased by 22.0% to $1.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 22.0%, from $1.43B to $1.11B.
other_increase_decrease_in_operating_capital_excluding_d_bb8272| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $126.00M | -$237.00M | $875.00M | $849.00M | $367.00M | $1.53B | $718.00M | $9.00M | $787.00M | $216.00M | -$30.00M | $1.43B | $1.11B |
| QoQ Change | — | -288.1% | +469.2% | -3.0% | -56.8% | +317.7% | -53.2% | -98.7% | >999% | -72.6% | -113.9% | >999% | -22.0% |
| YoY Change | — | — | — | +573.8% | +254.9% | +75.2% | -15.4% | -97.5% | -48.7% | -69.9% | -433.3% | +81.1% | -22.0% |